Investor Relations
Investor Relations
The Quigley Corporation (NASDAQ: QGLY) is a Natural Health Medical Science Company that manufactures and markets over the counter consumer cold remedy brands and is developing potential prescription and non-prescription pharmaceutical products through its Quigley Pharma Inc. subsidiary.
Please click on the links to the left for detailed information regarding the company, its financial performance, past press releases, SEC filings and Stock Information. If you would like to receive ongoing Email News alerts, there is also an area where you can sign up for those.
Latest News
12/03/09
QUIGLEY CEO, TED KARKUS, ANNOUNCES PHASE ONE OF 2010 STRATEGIC PLAN
07/22/09
QUIGLEY CORPORATION ANNOUNCES FINAL RESULTS OF QUIGLEY PHARMA'S PHASE IIB STUDY
07/17/09
TED KARKUS NAMED CEO OF THE QUIGLEY CORPORATION
Email Updates
- Sign up for timely updates from Quigley Pharma, Inc.

![[Qlogo.gif] [Qlogo.gif]](http://www.quigleypharma.com/uploads/images/Qlogo.gif)